Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Huemer

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Annals of the Rheumatic Diseases|June 8, 2010
Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trialIris Vilca, Pablo Garcia Munitis, Angela Pistorio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven yearsDaniel J Lovell, Nicolino Ruperto, Richard Mouy, et al.
Arthritis and Rheumatism|March 2, 2010
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
Pediatric Rheumatology Online Journal|February 24, 2015
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaborationLakshmi Nandini Moorthy, Elizabeth Roy, Vamsi Kurra, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Annals of the Rheumatic Diseases|June 8, 2010
Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trialIris Vilca, Pablo Garcia Munitis, Angela Pistorio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 23, 2015
Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven yearsDaniel J Lovell, Nicolino Ruperto, Richard Mouy, et al.
Arthritis and Rheumatism|March 2, 2010
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritisNicolino Ruperto, Daniel J Lovell, Pierre Quartier, et al.
Pediatric Rheumatology Online Journal|February 24, 2015
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaborationLakshmi Nandini Moorthy, Elizabeth Roy, Vamsi Kurra, et al.
Pageof 2